Dermaline

Dermaline is a South Korean dermacosmetics company founded in 2015 [11] and based in Hanam-si, Gyeonggi-do, just outside Seoul. The name is a portmanteau of "dermatology" and "cosmetic line" [11], and the company positions itself as a skin-science brand whose formulas grew out of years spent developing skincare for hospitals and clinics. It is led by chief executive Wang Honggeun [2].

The company operates a dual identity: a consumer skincare line built around clinical-grade actives such as PDRN and exosomes, and a medical-device business supplying lifting threads, skin boosters and hyaluronic-acid fillers [7]. Its products are sold across more than 40 countries, and a 2025 editorial described one of its toners as "the holy grail of PDRN toners" [10].

According to a reseller account of the brand, Dermaline was established in 2015 and began manufacturing and distributing professional derma-cosmetics in Korea that year. The 2015 founding date is repeated by the trade press and a B2B directory profile [7][8]; the company's own English homepage does not state a founding year, though it carries a 2018 Korean e-commerce permit consistent with a later move into direct online sales.

The founders are not publicly named. The company is registered as Dermaline Co., Ltd. and has been led by Wang Honggeun, whose name also appears in other romanizations — "Wang Hong Geun" in a trade directory and "Honkun Wang" in trade-press coverage — all rendering the same Korean name [8][7].

Dermaline describes itself as a "dermatology brand that provides solutions for healthy skin," crediting expertise built up through "developing skin care products at hospitals for many years." Its stated tagline is "Dermacosmetics for skin recovery," and it summarises its outlook as a "Brand With Skin Science." The company says its goal is to "create real cosmeceuticals" — high-functioning products it frames as backed by fundamental, fact-based science rather than marketing alone.

The positioning sits at the professional end of the market. The brand presents itself as offering clinically oriented formulas at an accessible price, and frames much of its range around three concerns: anti-ageing, moisturising and blemish-prone "trouble" skin.

Dermaline's catalogue centres on toners, ampoules, emulsions, eye patches and modeling masks, organised into several named lines including Hycare, Hypure, Bio Activing and the premium D'LEXO range. Signature items include the Hycare PDRN Solution Toner, the Bio Activing PDRN Eye Patch, and D'LEXO toners built around cica exosome and NAD technology. The company's hero ingredients span PDRN (described as salmon-derived DNA), NAD, glutathione, collagen, bakuchiol, peptides, exosomes and cica.

On the medical-device side, the company markets branded products such as DERMAVLINE and LUMINOVE MILK EXO alongside lifting threads and HA fillers [7]. For its consumer formulas, Dermaline points to dermatologist-driven testing and ISO-certified manufacturing [9], and states that its cica exosome toner carries an EWG Green grade for all ingredients. Several products are presented as dual-function items combining whitening and wrinkle-improvement benefits.

Editorial coverage of Dermaline has been concentrated in K-beauty trade and specialist press rather than mainstream Western beauty titles. A 2025 review of PDRN skincare singled out the Dermaline PDRN Toner, calling it "the holy grail of PDRN toners" and noting its availability through the Korean retailer Olive Young [10]. The brand has not been documented as the recipient of formal industry awards in the available sources.

Dermaline is an active manufacturer. As of 2024 it reported roughly USD 3 million in export sales and said it supplies products to more than 40 countries, maintaining exclusive distribution agreements with 33 partners and entering over 20 markets including Poland, Spain and Germany [7]. In March 2025 it exhibited lifting threads and skin-aesthetic solutions at KIMES 2025 in Seoul, and said it was pursuing ANVISA certification in Brazil to expand into the wider South American market.

Dermaline shares its name with an unrelated company. The brand documented here is the Korean dermacosmetics manufacturer at dermaline.co.kr. A separate business trading as Dermaline in the United States describes itself as originally from the Dominican Republic, founded more than 60 years ago and focused on skin-brightening products for the Hispanic and ethnic market [12]. The two are distinct entities that happen to share the Dermaline name.